research use only
Cat.No.S6799
| Related Targets | CDK HSP PD-1/PD-L1 ROCK Wee1 DNA/RNA Synthesis Microtubule Associated Ras KRas Aurora Kinase |
|---|---|
| Other Nur77 Inhibitors | Cytosporone B (Csn-B) C-DIM5 DIM-C-pPhCO2Me |
| Cell Lines | Assay Type | Concentration | Incubation Time | Formulation | Activity Description | PMID |
|---|---|---|---|---|---|---|
| MCF7 | Anticancer assay | 2 uM | 24 hrs | Anticancer activity against human MCF7 cells assessed as cell death at 2 uM after 24 hrs by MTT assay | 22104151 | |
| MCF7 | Function assay | 2 uM | 24 hrs | Inhibition of tubulin polymerization in human MCF7 cells at 2 uM after 24 hrs by FITC-conjugated immunostaining assay | 22104151 | |
| MCF7 | Function assay | 2 uM | 24 hrs | Inhibition of HDAC1 protein expression in human MCF7 cells at 2 uM after 24 hrs by Western blotting | 22104151 | |
| MCF7 | Function assay | 2 uM | 24 hrs | Inhibition of HDAC2 protein expression in human MCF7 cells at 2 uM after 24 hrs by Western blotting | 22104151 | |
| MCF7 | Function assay | 2 uM | 24 hrs | Inhibition of HDAC3 protein expression in human MCF7 cells at 2 uM after 24 hrs by Western blotting | 22104151 | |
| MCF7 | Function assay | 2 uM | 24 hrs | Inhibition of HDAC8 protein expression in human MCF7 cells at 2 uM after 24 hrs by Western blotting | 22104151 | |
| MCF7 | Function assay | 8 uM | 24 hrs | Induction of apoptosis in human MCF7 cells assessed as PARP-cleavage at 8 uM after 24 hrs by Western blot analysis | 22104151 | |
| MCF7 | Function assay | 8 uM | 24 hrs | Induction of apoptosis in human MCF7 cells assessed as caspase-7 activation at 8 uM after 24 hrs by Western blot analysis | 22104151 | |
| Click to View More Cell Line Experimental Data | ||||||
|
In vitro |
DMSO
: 200 mg/mL
(591.01 mM)
Ethanol : 68 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 338.40 | Formula | C23H18N2O |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 151358-47-3 | -- | Storage of Stock Solutions |
|
|
| Synonyms | C-DIM8, CDIM8 | Smiles | C1=CC=C2C(=C1)C(=CN2)C(C3=CC=C(C=C3)O)C4=CNC5=CC=CC=C54 | ||
| Targets/IC50/Ki |
Nur77
(786-O cells based assay) 13.0 μM
Nur77
(ACHN cells based assay) 13.6 μM
|
References |
|---|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.